Diamyd Medical: Mertiva will be delisted from NasdaqOMX and will be listed on another marketplace

Regulatory News:

At a Board meeting on April 22, 2013 in Mertiva AB (previously Diamyd Medical AB), it was decided that the company should apply for delisting from NasdaqOMX. It was also decided that the company should be listed on another equities marketplace.

The date for the delisting from NasdaqOMX will be decided together with NasdaqOMX. The intention is that the company should be listed on Aktietorget or another similar equities marketplace at the same time as the share is delisted from NasdaqOMX.

About Mertiva Mertiva AB (former Diamyd Medical) primarily consists of holdings in liquid assets and holdings in Protein Sciences Corporation and Mercodia AB.

Mertiva (former Diamyd Medical) shares are listed on Nasdaq OMX (segment Small Cap) in Stockholm (ticker: DIAM B) and on OTCQX in the US (ticker: DMYDY) administered by the Pink OTC Markets and the Bank of New York Mellon (PAL).

More information can be found at www.mertiva.se

This information is disclosed in accordance with the Swedish Securities Markets Act, the Swedish Financial Instruments Trading Act, or the requirements stated in the listing agreements.

Mertiva AB (publ) Karlavägen 108, SE-115 26 Stockholm, Sweden. E-mail: info@mertiva.com. Reg. no: 556530-1420

This information was brought to you by Cision http://news.cision.com